Continuous renal replacement therapy-the new treatment of seriously hyperglycemia
Continuous renal replacement therapy-the new treatment of seriously hyperglycemia
复制标题
DOI:
10.1016/j.ajem.2016.06.061
复制
发表时间:
2016-12-01
影响因子:
3.6
通讯作者:
Chen, Yanmei
中科院分区:
文献类型:
--
作者:
Tang, Qian;Li, Zhiyong;Chen, Yanmei
Diabetic ketoacidosis (DKA) and hypertonic hyperglycemia syndrome (HHS), acute and potentially life-threatening complications of diabetes mellitus, are frequently the result of a precipitating illness or nonadherence to treatment. This study aimed to report one successful case of DKA cocurrent HHS, with blood glucose level reaching up to 1969 mg/dL, treated with continuous renal replacement therapy (CRRT), and to provide a review of the medical literature. The clinic and hospital medical records of 1 subject with type 2 diabetes mellitus and unexplained DKA cocurrent HHS are reviewed. An electronic MEDLINE search of relevant medical literature published from 2000 to 2016 was performed. In addition, the reference lists of the identified articles and other sources, such as textbook chapters and meeting abstracts, were reviewed for related publications. To date, there have been no reports on patients with serious condition whose blood glucose level was up to 1881 mg/dL and who underwent CRRT treatment of acute kidney injury caused by DKA and HHS. The case provides a new method for DKA or HHS treatment for patients who have very high level of blood glucose that cannot only use insulin glargine treatment. In conclusion, CRRT can be used not only to treat diabetic nephropathy but also to treat DKA or HHS to reduce blood glucose.